Sun, Mar 1, 2015, 10:45 AM EST - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

ImmunoGen, Inc. Message Board

  • bioimmunomabman bioimmunomabman Jun 17, 2013 8:59 AM Flag

    JNJ acquires phase II co for $650MM

    Another signal that IMGN is highly undervalued, Aragon acquired for $650MM based on a drug in phase II for PC and earlier development for BC. IMGN's business execs fails to deliver full market value for IMGN shareholders. If this continues for much longer, the solutions are an acquisition, or removal and replacement of said failing execs.

7.60-0.19(-2.44%)Feb 27 4:00 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Auspex Pharmaceuticals, Inc.
NASDAQFri, Feb 27, 2015 4:00 PM EST
Herbalife Ltd.
NYSEFri, Feb 27, 2015 4:01 PM EST